Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Generation and characterization of a Meflin-CreERT2 transgenic line for lineage tracing in white adipose tissue.

Kuwano T., Izumi H., Aslam MR., Igarashi Y., Bilal M., Nishimura A.

Animal Study, published in PLoS One (2021) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
PLoS One (2021)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
33760832
PMCID
PMC7990287
DOI
10.1371/journal.pone.0248267
Citations
8

Abstract (original English)

Meflin (Islr) expression has gained attention as a marker for mesenchymal stem cells, but its function remains largely unexplored. Here, we report the generation of Meflin-CreERT2 mice with CreERT2 inserted under the Meflin gene promoter to label Meflin-expressing cells genetically, thereby enabling their lineages to be traced. We found that in adult mice, Meflin-expressing lineage cells were present in adipose tissue stroma and had differentiated into mature adipocytes. These cells constituted Crown-like structures in the adipose tissue of mice after high-fat diet loading. Cold stimulation led to the differentiation of Meflin-expressing lineage cells into beige adipocytes. Thus, the Meflin-CreERT2 mouse line is a useful new tool for visualizing and tracking the lineage of Meflin-expressing cells.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose Tissue, WhiteAnimalsCell DifferentiationCell LineageGene ExpressionImmunoglobulinsMesenchymal Stem CellsMiceMice, Inbred C57BLMice, Transgenic

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.